A detailed history of Keystone Wealth Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Keystone Wealth Services, LLC holds 4,618 shares of ABBV stock, worth $761,923. This represents 0.27% of its overall portfolio holdings.

Number of Shares
4,618
Previous 5,519 16.33%
Holding current value
$761,923
Previous $946,000 3.7%
% of portfolio
0.27%
Previous 0.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $147,619 - $179,596
-901 Reduced 16.33%
4,618 $911,000
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $8,358 - $9,761
-54 Reduced 0.97%
5,519 $946,000
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $34,521 - $39,333
-216 Reduced 3.73%
5,573 $1.01 Million
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $87,238 - $98,250
-634 Reduced 9.87%
5,789 $897,000
Q3 2023

Oct 05, 2023

SELL
$133.59 - $154.65 $148,552 - $171,970
-1,112 Reduced 14.76%
6,423 $957,000
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $56,714 - $70,577
-428 Reduced 5.37%
7,535 $1.02 Million
Q1 2023

Apr 07, 2023

SELL
$144.61 - $166.54 $4,338 - $4,996
-30 Reduced 0.38%
7,963 $1.27 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $18,118 - $21,728
131 Added 1.67%
7,993 $1.29 Million
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $1,476 - $1,693
-11 Reduced 0.14%
7,862 $1.06 Million
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $8,532 - $10,847
-62 Reduced 0.78%
7,873 $1.21 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $3,431 - $4,257
26 Added 0.33%
7,935 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $849,663 - $1.08 Million
7,909 New
7,909 $1.07 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Keystone Wealth Services, LLC Portfolio

Follow Keystone Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Wealth Services, LLC with notifications on news.